I would add to the above that it's possibly the 'pharmacokinetics' of NNZ-2591 (bioavailability, stability, half-life), rather than it's mechanism of action, that has caused Jon to call it the "jewel in the crown" for Neuren.
It looks to me Neuren may have made some compromises to get Trofinitide to work. NNZ-2591 appears closer to the 'ideal' pharmacokinetics you'd want in an effective drug. If its half-life is longer than Trofinitide too then doubly so.
- Forums
- ASX - By Stock
- NEU
- Neuren - where to from here ?
Neuren - where to from here ?, page-71
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 3429 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 18.000 |
2 | 582 | 17.950 |
2 | 650 | 17.500 |
2 | 2080 | 17.430 |
1 | 1 | 17.160 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 3429 | 4 |
15.390 | 5189 | 1 |
15.400 | 4017 | 16 |
15.450 | 3472 | 1 |
15.500 | 2548 | 2 |
Last trade - 13.05pm 08/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable